Ind-Swift Laboratories Ltd.
INDSWFTLAB Share PricePharmaceuticals & Drugs
₹106.41
4.4 (4.3%)
As on September 8, 2025
Exchange Scrips: BSE532305NSEINDSWFTLABISININE915B01019
Market Cap ₹ 783 Cr
P/E Ratio 1.49
Dividend Yield N/A
Performance
Market performance
Open103.05
High106.99
Volumes1,08,916
Prev106.41
Low101.5
As on2025-09-08
Historical performance
1 Year High151.36
3 Year High186
5 Year High186
1 Year Low68.72
3 Year Low52.65
5 Year Low32.55
Fundamentals
Company Valuation
Market Cap (₹Cr)
783
Face Value (₹)
10
P/E Ratio
1.49
Dividend Yield
N/A
Investment Returns
1 Year
-26.8%
3 Years
76.5%
5 Years
211.1%
10 Years
275.3%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 102.44 | Bullish |
| 10-DMA | 99.24 | Bullish |
| 20-DMA | 100.23 | Bullish |
| 50-DMA | 104.79 | Bullish |
| 100-DMA | 95.52 | Bullish |
| 200-DMA | 97.49 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 18 | 18 | 18 | 18 | 18 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 18 | 18 | 18 | 18 | 18 |
| Public Investors | 28691 | 28099 | 28734 | 28865 | 25443 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 1.49.
- 3Y Stock Price CAGR of the stock is 21.1.
- The stock has a beta of 0.6.
- In the last financial year, the company had an EBITDA of ₹2996 Million.
- The company generated revenue of ₹12809 Million in the previous financial year.
Ind-Swift Laboratories Ltd.
106.414.4 (4.3%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 750687.8
No. of Shares: 7055 (Approx)
Performance:-24.9%
P/L: ₹-249312.2
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent